Timothy Murphy, MD, FACP, practice president of Rocky Mountain Cancer Centers, spoke with The American Journal of Managed Care® about the effect of the COVID-19 pandemic on screening for lung cancer.
Timothy Murphy, MD, FACP, practice president of Rocky Mountain Cancer Centers, spoke with The American Journal of Managed Care® about the effect of the pandemic on screening for lung cancer.
Transcript
What impact did COVID-19 and the delay in diagnosis have on the patients with lung cancer who are coming into cancer practices now?
COVID-19 created a significant delay in diagnoses, not just in lung cancer but essentially all cancers across the board is what the data is looking like during the 2 quarters in 2020 where essentially everything was shut down. So, the rate of screening for lung cancer essentially went to zero, and what we're finding now that the system is open and back up and running, we're not getting the same amount of people coming in.
There was a real hesitancy during the end of 2020 and really into 2021 of people going back to the centers to get screened. So, we are not back to prepandemic levels of screening, and more importantly, and rather tragically, the cancers we are now diagnosing, specifically lung cancer, do appear to be in a later stage, likely as a result in the delay of that screening.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen